Skip to main content
Infectious Diseases and Therapy logoLink to Infectious Diseases and Therapy
. 2022 Jan 16;11(1):127. doi: 10.1007/s40121-021-00583-8

Correction to: Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States

Yiling Jiang 1,, Eric M Sarpong 2, Pamela Sears 2, Engels N Obi 2
PMCID: PMC8847657  PMID: 35034290

Correction to: Infect Dis Ther 10.1007/s40121-021-00480-0

In the original publication of the article the copyright line has been erroneously published as “The Authors” the correct copyright should be Merck & Co., Inc., Kenilworth, NJ, USA 2021

The copyright line has been corrected in this paper.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Infectious Diseases and Therapy are provided here courtesy of Springer

RESOURCES